No Data
No Data
TransCode Therapeutics Shares Are Trading Higher After the Company Announced It's Dosed Patients in the First Cohort of Its Phase 1A Dose-escalation Clinical Trial of TTX-MC138.
Express News | Transcode Therapeutics Inc - No Significant Safety or Dose Limiting Toxicities Reported
12 Health Care Stocks Moving In Thursday's Intraday Session
Express News | Transcode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial With First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial With First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics and Michigan State Target Metastatic Breast Cancer in New Study
No Data
No Data
73466496 : Why this stock is going down when news about this stock is positive